天堂网亚洲,天天操天天搞,91视频高清,菠萝蜜视频在线观看入口,美女视频性感美女视频,95丝袜美女视频国产,超高清美女视频图片
南通全益生物科技有限公司 公司信息
公司名稱:
南通全益生物科技有限公司
電話:
0513-66337626
電子郵件:
sales@chemhifuture.com
國籍:
中國
網(wǎng)址:
https://www.chemhifuture.com/
產(chǎn)品總數(shù):
5686
52
53
54
55
56
57
公司提供產(chǎn)品列表
PF-06372222
1407592-99-7
3-(5-bromo-1H-indol-3-yl)-2,2-dimethylpropyl acetate
2641451-61-6
Mito-TRFS
TRFS-red
Balomenib
2939850-17-4
Aleniglipron/GSBR-1290
2685823-26-9
Thiamine Triphosphate
3475-65-8
Glycerylphosphorylcholine
563-24-6
iBFAR2
353484-02-3
Quisinostat (JNJ-26481585)
875320-29-9
IPG-1 AM
1369302-18-0
Glycerophosphoinositol choline
425642-32-6
KDOAM25
2230731-99-2
Colibactin 742
2916559-62-9
(9s,10s)-9,10-Dihydro-9,10-[1,2]benzenoanthracene-1,4-diol
5969-70-0
AG-7404
343565-99-1
1110768-13-2
1110768-13-2
3-[(2S)-2-amino-3-methylbutanamido]propane-1-sulfonic acid
1034190-08-3
2'-chloro-5'-methoxy-6-methyl-[4,4'-bipyridine]-3-carboxylic acid
2'-氯-5'-甲氧基-6-甲基-[4,4'-聯(lián)吡啶]-3-甲酸
2782812-46-6
ATR-IN-29
2761193-67-1
Clerosterol
2364-23-0
Ivonescimab
2428381-53-5
11-cis Retinoic Acid
68070-35-9
ML307
STING agonist-29
2868261-51-0
GNE7599
2771069-76-0
Trastuzumab emtansine
曲妥珠單抗
1018448-65-1
Pembrolizumab (anti-PD-1)
RIBI-529
216014-46-9
KRASG12D-IN-3
3033638-63-7
Fluotrimazol
31251-03-3
Linustedastatum
2254299-48-2
AG-041R
159883-95-1
DGN549-C
2058075-34-4
Isoleucyl tRNA synthetase-IN-2
2494195-61-6
rac-5-Methyl Tetrahydropteroic Acid Sodium Salt
4349-41-1
Nicorandil Impurity 16
1157-74-0
(S)-2-(((Benzyloxy)carbonyl)amino)-2-((tert-butoxycarbonyl)amino)acetic acid
1932778-68-1
Zurletrectinib/ICP-723
2403703-30-8
KRASG12D-IN-3-d3
3033638-69-3
RP03707
3030493-05-8
HRS-4642
2836263-09-1
65141-56-2
65141-56-2
Dihydroxanthopterin
1131-35-7
GIP/GLP-1 dual receptor agonist-1
2807481-02-1
Epyrifenacil
353292-31-6
L18-MDP
60398-08-5
Menin-MLL inhibitor-22
2851841-61-5
tert-butyl 4-[5-bromo-6-[(1S)-1-methoxyethyl]pyridin-3-yl]piperazine-1-carboxylate
2641824-76-0
Obatoclax
803712-67-6
(R)-2-(1-amino-2-(2,5-dibromophenyl)ethyl)-5-bromopheno
1585969-24-9
23-Oxa-OSW-1
790224-37-2
GDC-2394
2238822-08-5
ITK degrader 2
2858738-65-3
2714410-97-4
2714410-97-4
VT02956
2999763-09-4
BMV109
1458731-58-2
Elsibucol
216167-95-2
BWC0977
2254567-00-3
3-((5-Bromopyridin-2-yl)oxy)
189954-65-2
SR 142948
184162-64-9
Ledaborbactam etzadroxil
1842399-68-1
Abemaciclib metabolite M18
2704316-81-2
Fenoterol hydrobromide
1944-12-3
Natalizumab
那他珠單抗
189261-10-7
Imdevimab
伊姆德維馬布
ASP3082
Duvyzat
497833-27-9
OG-L002
1357302-64-7
Mitoquinol
845959-55-9
Tezepelumab
特折魯單抗
1572943-04-4
Trastuzumab Deruxtecan
德盧替康-曲妥珠單抗
1826843-81-5
Mepolizumab
美泊麗單抗
196078-29-2
Ocrelizumab
奧克立珠單抗
637334-45-3
Dupliumab
度匹魯單抗
1190264-60-8
Tocilizumab
托珠單抗
375823-41-9
Pertuzumab
帕妥珠單抗
380610-27-5
AUR-1545
3031593-79-7
AMrubicin hydrochloride
92470-31-0
Epitinib
1203902-67-3
Sarilumab
1189541-98-7
Risankizumab
瑞莎珠單抗
Benralizumab
貝那利珠單抗
1044511-01-4
Org 25543
363628-88-0
Aducanumab
阿杜那單抗
1384260-65-4
Efmoroctocog alfa
1270012-79-7
Anti-MouseVEGFR-2Antibody(DC101)
(R)-8-Cyclopentyl-2-((1-(2-((3R,5S)-3,5-dimethylpiperazin-1-yl)acetyl)-6-methoxyindolin-5-yl)amino)-7-ethyl-5-methyl-7,8-dihydropteridin-6(5H)-one
3063893-60-4
Ramucirumab (anti-VEGFR)
947687-13-0
Panitumumab
帕尼單抗
339177-26-3
Casirivimab
卡西里維馬布
Lecanemab
侖卡奈單抗
1260393-98-3
5-TMRIA [Tetramethylrhodamine-5-Iodoacetamide Dihydroiodide
114458-99-0
Alemtuzumab
阿倫單抗
216503-57-0
Benzoquinazolinone 12
1227923-91-2
DRF-1042
200619-13-2
Emicizumab
艾米珠單抗
1610943-06-0
PROTAC BTK Degrader-12
2736508-65-7
Cytochalasin D/Zygosporin A/NSC 209835
細胞松弛素D
22144-77-0
(E)-2-Hydroxyoctadec-9-enoic acid
56472-31-2
52
53
54
55
56
57
Copyright 2007? ChemicalBook. All rights reserved.